Rhumbline Advisers Eli Lilly & CO Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Eli Lilly & CO stock. As of the latest transaction made, Rhumbline Advisers holds 1,514,658 shares of LLY stock, worth $1.18 Billion. This represents 1.23% of its overall portfolio holdings.

Number of Shares

1,514,658

Previous 1,579,402 4.1%

Holding current value

$1.18 Billion

Previous $1.43 Billion 6.16%

% of portfolio

1.23%

Previous 1.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $50 Million - $62.2 Million	-64,744 Reduced 4.1%	1,514,658 $1.34 Billion
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $28.1 Million - $35.2 Million	38,762 Added 2.52%	1,579,402 $1.43 Billion
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $15,989 - $21,391	-27 Reduced -0.0%	1,540,640 $1.2 Billion
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $7.43 Million - $8.76 Million	-14,145 Reduced 0.91%	1,540,667 $898 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $4.18 Million - $5.76 Million	9,618 Added 0.62%	1,554,812 $835 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $5.86 Million - $7.84 Million	16,711 Added 1.09%	1,545,194 $725 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $18.2 Million - $21.3 Million	58,471 Added 3.98%	1,528,483 $525 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $18.9 Million - $22 Million	58,785 Added 4.17%	1,470,012 $538 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $8.45 Million - $9.63 Million	28,492 Added 2.06%	1,411,227 $456 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $8.7 Million - $10.2 Million	31,229 Added 2.31%	1,382,735 $448 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $4.73 Million - $5.87 Million	20,139 Added 1.51%	1,351,506 $387 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $5.01 Million - $6.21 Million	22,262 Added 1.7%	1,331,367 $368 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $8.3 Million - $10.2 Million	-37,477 Reduced 2.78%	1,309,105 $302 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $12.4 Million - $16.1 Million	-68,918 Reduced 4.87%	1,346,582 $309 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $15.8 Million - $20.4 Million	-95,984 Reduced 6.35%	1,415,500 $264 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $3.25 Million - $4.3 Million	-24,882 Reduced 1.62%	1,511,484 $255 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $2.16 Million - $2.5 Million	-14,780 Reduced 0.95%	1,536,366 $227 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $13.5 Million - $16.3 Million	99,105 Added 6.83%	1,551,146 $255 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $1.79 Million - $2.21 Million	-15,011 Reduced 1.02%	1,452,041 $201 Million
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $1.89 Million - $2.34 Million	-17,652 Reduced 1.19%	1,467,052 $193 Million
Q3 2019 Oct 23, 2019	BUY	$106.79 - $116.16 $3.08 Million - $3.35 Million	28,867 Added 1.98%	1,484,704 $166 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $7.61 Million - $8.88 Million	-68,660 Reduced 4.5%	1,455,837 $161 Million
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $1.57 Million - $1.85 Million	-14,146 Reduced 0.92%	1,524,497 $198 Million
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $1.37 Million - $1.54 Million	12,962 Added 0.85%	1,538,643 $178 Million
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $2.76 Million - $3.45 Million	-32,180 Reduced 2.07%	1,525,681 $164 Million
Q2 2018 Aug 06, 2018	BUY	$75.7 - $86.88 $1.41 Million - $1.61 Million	18,581 Added 1.21%	1,557,861 $133 Million
Q1 2018 May 02, 2018	SELL	$74.21 - $87.6 $2.78 Million - $3.29 Million	-37,509 Reduced 2.38%	1,539,280 $119 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $2.9 Million - $3.11 Million	35,349 Added 2.29%	1,576,789 $133 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $119 Million - $132 Million	1,541,440	1,541,440 $132 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Eli Lilly & CO Transaction History